血清胃蛋白酶原、CEA、CA199、CA724与胃泌素17联合检测在胃癌早期诊断中的应用价值分析

江唯波; 陈淼; 虞信维

doi:10.3969/j.issn.1671-038X.2017.11.08

血清胃蛋白酶原、CEA、CA199、CA724与胃泌素17联合检测在胃癌早期诊断中的应用价值分析

- 宁波市奉化区人民医院检验科, 浙江宁波 315500

详细信息

作者简介:
江唯波,女,本科,主管技师,研究方向:免疫学方向

通讯作者: 江唯波,E-mail:ddd23yyyi@163.com

中图分类号: R735.2

收稿日期: 2017-08-01

Clinical value of serum pepsinogen, CEA, CA199, CA724 and gastrin 17 combined detection in early diagnosis of gastric cancer

- Department of Clinical Laboratory, the People's Hospital of Fenghua District, Zhejiang Ningbo 315500, China

More Information

Corresponding author: JIANG Wei-bo, E-mail: ddd23yyyi@163.com

Received Date: 01 August 2017

摘要

摘要: [目的]探讨血清胃蛋白酶原(PGⅠ、PGⅡ)、癌胚抗原(CEA)、糖蛋白抗原19-9(CA199)、糖蛋白抗原-724(CA724)与胃泌素17(GAS-17)联合检测在胃癌早期诊断中的应用价值。[方法]收集我院2015年1月~2016年12月收治胃癌患者65例(胃癌组),另外选取同期胃良性疾病者47例(胃良性疾病组)、正常健康体检者45例(正常对照组)。分析三组患者PGⅠ、PGⅡ、CEA、CA199、CA724与GAS-17水平,比较各项指标单独检测及联合检测对胃癌早期诊断的灵敏度及特异度。[结果]3组患者PGⅠ、PGⅡ、CEA、CA199、CA724及GAS-17指标水平存在明显差异,数据差异具有统计学意义(P<0.05);随疾病程度升高,PGⅠ、CA724指标水平逐渐下降(P<0.05),而PGⅡ、CEA、CA199、GAS-17指标水平逐渐升高(P<0.05);PGⅠ、PGⅡ、CEA、CA199、CA724及GAS-17水平在各期胃癌中存在明显差异,随着胃癌病理分期的增高,PGⅠ、PGⅡ、CEA、CA199、CA724及GAS-17水平呈现逐渐上升趋势(P<0.05);单独检测诊断胃癌灵敏度及特异度最高的指标分别为CA199(67.69%)和CA724(90.76%),PGⅠ+PGⅡ+CEA+CA199+CA724+GAS-17联合检测胃癌特异度及灵敏度分为98.46%、76.92%,明显高于单独指标检测(P<0.05)。[结论]PGⅠ、PGⅡ、CEA、CA199、CA724及GAS-17指标联合检测能够提高胃癌早期诊断的特异度及灵敏度,其可为临床早期诊断、制定治疗方案提供相关参考。
- 血清胃蛋白酶原 /
- 联合检测 /
- 胃癌 /
- 早期诊断
Abstract: [Objective]To investigate the clinical value of serum pepsinogen(PG I and PG II),carcinoembryonic antigen(CEA),carbohydrate antigen 19-9(CA199),carbohydrate antigen-724(CA724)and gastrin 17(GAS-17)in early diagnosis of gastric cancer.[Methods]A total of 65 patients with gastric cancer(gastric cancer group)treated in our hospital from January 2015 to December 2016 were enrolled.In addition,47 patients with benign gastric diseases(benign gastric diseases group)and 45 healthy subjects were selected(normal control group).The PG I,PG II,CEA,CA199,CA724 and GAS-17 levels in the three groups were analyzed.The sensitivity and specificity of each index individually and combined detection in the early diagnosis of gastric cancer were compared.[Results]The levels of PG I and PG II,CEA,CA199,CA724 and GAS-17 were significant difference among three groups(P＜0.05).With the severity of the disease increased,the levels of PG I and CA724 significantly decreased(P＜0.05).With the extent of the disease increased,the levels of PG II,CEA,CA199,GAS-17 significantly increased(P＜0.05).The levels of PG I and PG II,CEA,CA199,CA724 and GAS-17 were obviously different in different stages of gastric cancer,and with increased pathological staging of gastric cancer,the levels of PG I and PG II,CEA,CA199,CA724 and GAS-17 levels showed a gradual upward trend(P＜0.05).The highest sensitivity of single detection of gastric cancer was CA199(67.69%)and the highest specificity single detection of gastric cancer was CA724(90.76%).The specificity and sensitivity of PG I+PG II +CEA+CA199+CA724+GAS-17 combined detection in early diagnosis of gastric cancer were 98.46% and 76.92%,which was significantly higher than that of single index detection(P＜0.05).[Conclusion]The combined detection of PG I,PG II,CEA,CA199,CA724 and GAS-17 markers can improve the specificity and sensitivity of early diagnosis of gastric cancer.It can provide reference for early clinical diagnosis and the establishment of treatment programs.
- serum pepsinogen /
- combined detection /
- gastric cancer /
- early diagnosis

HTML全文

参考文献(20)

[1]	李林, 张立新, 艾冬琴, 等.血清胃蛋白酶原和胃泌素-17检测在胃癌筛查中的应用[J].海南医学, 2015, 26 (22):3335-3337.
[2]	张俊, 王永斌, 彭海林, 等.血清胃蛋白酶原和CEA及CA199与CA724联合检测对胃癌诊断价值研究[J].中华肿瘤防治杂志, 2015, 21 (22):176-178.
[3]	王胜, 单绿虎, 束新华, 等.血清胃蛋白酶原及CA199、CA242、CEA联合检测在胃癌早期诊断中的价值[J].中华全科医学, 2016, 14 (4):646-648.
[4]	周秀萍, 吴静, 赵颖.肿瘤标志物联检在胃癌早期诊断的应用价值分析[J].中华肿瘤防治杂志, 2015, 21 (22):141-142.
[5]	汪桂霞.胃癌行CA724、CEA、CA242、CA199肿瘤标志物联合检测的价值[J].现代中西医结合杂志, 2015, 24 (4):430-431.
[6]	杜娟, 杨磊, 席妍, 等.血清胃蛋白酶原及肿瘤标志物联合检测在老年胃癌诊断中的意义[J].中国医药导报, 2015, 12 (32):97-99.
[7]	钱磊, 陈为军.血清胃蛋白酶原在胃癌早期诊断中的应用意义及价值评析[J].中国实验诊断学, 2016, 19 (2):243-245.
[8]	闫真, 邵淑琳, 张杰, 等.血清胃蛋白酶原联合胃泌素17检测在胃癌筛查中的价值[J].中国医药, 2016, 11 (12):1795-1799.
[9]	陈卿奇, 羊文芳, 吴素江, 等.血清胃蛋白酶原及胃泌素-17水平与胃癌的相关性研究[J].重庆医学, 2016, 45 (35):4938-4941.
[10]	朱春平, 赵建业, 申晓军, 等.血清胃泌素-17联合胃蛋白酶原检测对胃癌诊断价值的多中心临床研究[J].中华消化内镜杂志, 2017, 34 (1):19-23.
[11]	乔正梅, 王登峰, 赵秋剑, 等.血清胃蛋白酶原、胃泌素-17在胃癌及胃癌前病变的诊断价值[J].中国卫生检验杂志, 2017, 26 (2):198-200.
[12]	黄喜顺, 邓立新, 邱耀辉, 等.血清PG、G-17联合CA72-4和13CUBT在早期胃癌的诊断价值[J].重庆医学, 2017, 46 (10):1346-1348.
[13]	王霄腾, 蔡利军, 吕宾, 等.血清幽门螺杆菌抗体联合胃蛋白酶原检测在胃癌和癌前病变筛查中的应用[J].中华消化杂志, 2016, 36 (9):582-587.
[14]	张航, 王琼, 张婷.幽门螺杆菌检测在胃癌诊断中的临床意义[J].中国中西医结合消化杂志, 2017, 24 (2):135-138.
[15]	董梁.Hsp90及其受体蛋白ILK在胃癌及癌前病变中的表达及意义[J].中国中西医结合消化杂志, 2016, 23 (4):271-274.
[16]	简文, 赵颖.胃癌防治知识对胃癌患者早期诊断影响的调查研究[J].实用临床医药杂志, 2015, 19 (22):31-33.
[17]	周萍, 王聪, 赵车冬, 等.CEA、CA199、CA125、CA724联合检测对胃癌的临床诊断价值[J].实用癌症杂志, 2017, 32 (9):1427-1429.
[18]	Suhir E.Method and assay for the non-invasive detection of early gastric cancer bt the combined use of methylated reprimo cell-free DNA and pepsinogen I/II[J].J Appl Phy, 2015, 88 (5):2363-2370.
[19]	Ohashi T, Komatsu S, Ichikawa D, et al.Tumor Index as a Combined Indicator of Tumor Depth and Size in Gastric Cancer[J].Anticancer Research, 2016, 36 (4):1895-1895
[20]	周娥.血清CEA、CA125、CA199及血浆M2-PK联合检测在胃癌诊断中的价值分析[J].检验医学与临床, 2016, 13 (16):2360-2362.